Kulp SK[au] - Search Results

Year	Number of Results
1992	1
1993	2
1996	4
1997	3
1998	3
2000	2
2002	5
2004	4
2005	2
2006	1
2007	6
2008	9
2009	11
2010	9
2011	10
2012	9
2013	8
2014	6
2015	7
2016	8
2017	4
2018	3
2019	6
2020	5
2021	3
2022	2
2023	2

1

Chu PC, Kulp SK, Chen CS. Chu PC, et al. Among authors: kulp sk. Carcinogenesis. 2017 Jan;38(1):105-106. doi: 10.1093/carcin/bgw117. Epub 2016 Nov 21. Carcinogenesis. 2017. PMID: 28064180 Free PMC article. Retracted. No abstract available.

2

Pharmacological strategies to target oncogenic KRAS signaling in pancreatic cancer.

Chuang HC, Huang PH, Kulp SK, Chen CS. Chuang HC, et al. Among authors: kulp sk. Pharmacol Res. 2017 Mar;117:370-376. doi: 10.1016/j.phrs.2017.01.006. Epub 2017 Jan 8. Pharmacol Res. 2017. PMID: 28077300 Review.

3

Retraction of "Development of Novel Adenosine Monophosphate-Activated Protein Kinase Activators".

Guh JH, Chang WL, Yang J, Lee SL, Wei S, Wang D, Kulp SK, Chen CS. Guh JH, et al. Among authors: kulp sk. J Med Chem. 2018 Jun 14;61(11):5055. doi: 10.1021/acs.jmedchem.8b00707. Epub 2018 May 18. J Med Chem. 2018. PMID: 29772897 Free PMC article. No abstract available.

4

PPARgamma-independent antitumor effects of thiazolidinediones.

Wei S, Yang J, Lee SL, Kulp SK, Chen CS. Wei S, et al. Among authors: kulp sk. Cancer Lett. 2009 Apr 18;276(2):119-24. doi: 10.1016/j.canlet.2008.08.008. Epub 2008 Sep 13. Cancer Lett. 2009. PMID: 18790559 Free PMC article. Review.

5

Retraction of "Development of a Novel Class of Glucose Transporter Inhibitors".

Wang D, Chu PC, Yang CN, Yan R, Chuang YC, Kulp SK, Chen CS. Wang D, et al. Among authors: kulp sk. J Med Chem. 2018 Jun 14;61(11):5056. doi: 10.1021/acs.jmedchem.8b00708. Epub 2018 May 18. J Med Chem. 2018. PMID: 29772905 Free PMC article. No abstract available.

6

Retraction: Antitumor Effects of a Novel Phenylbutyrate-based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer.

Kulp SK, Chen CS, Wang DS, Chen CY, Chen CS. Kulp SK, et al. Clin Cancer Res. 2019 May 1;25(9):2940. doi: 10.1158/1078-0432.CCR-19-0731. Clin Cancer Res. 2019. PMID: 31043388 No abstract available.

7

Indole-3-carbinol as a chemopreventive and anti-cancer agent.

Weng JR, Tsai CH, Kulp SK, Chen CS. Weng JR, et al. Among authors: kulp sk. Cancer Lett. 2008 Apr 18;262(2):153-63. doi: 10.1016/j.canlet.2008.01.033. Epub 2008 Mar 7. Cancer Lett. 2008. PMID: 18314259 Free PMC article. Review.

8

Retraction: Non-epigenetic function of HDAC8 in regulating breast cancer stem cells by maintaining Notch1 protein stability.

Chao MW, Chu PC, Chuang HC, Shen FH, Chou CC, Hsu EC, Himmel LE, Huang HL, Tu HJ, Kulp SK, Teng CM, Chen CS. Chao MW, et al. Among authors: kulp sk. Oncotarget. 2020 Mar 24;11(12):1096. doi: 10.18632/oncotarget.27533. eCollection 2020 Mar 24. Oncotarget. 2020. PMID: 32256981 Free PMC article.

9

AMPK as a potential anticancer target - friend or foe?

Chuang HC, Chou CC, Kulp SK, Chen CS. Chuang HC, et al. Among authors: kulp sk. Curr Pharm Des. 2014;20(15):2607-18. doi: 10.2174/13816128113199990485. Curr Pharm Des. 2014. PMID: 23859619 Free PMC article. Review.

10

Pharmacological exploitation of indole-3-carbinol to develop potent antitumor agents.

Weng JR, Omar HA, Kulp SK, Chen CS. Weng JR, et al. Among authors: kulp sk. Mini Rev Med Chem. 2010 May;10(5):398-404. doi: 10.2174/138955710791330945. Mini Rev Med Chem. 2010. PMID: 20370707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year